Given the high association between NAFLD/NASH and cardiovascular diseases53, 54, increased levels of vigilin in hepatic steatosis may therefore provide a potential link to increased risks for cardiovascular diseases. The gene discussed is HDLBP; the disease is metabolic dysfunction-associated steatotic liver disease.